{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:49:12Z","timestamp":1792900152987,"version":"4.5.0"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Dexmedetomidine is a widely used sedative in the intensive care unit (ICU) and has unique properties that may be associated with reduced occurrence of new-onset atrial fibrillation (NOAF).<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To investigate whether the use of dexmedetomidine is associated with the incidence of NOAF in patients with critical illness.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This propensity score\u2013matched cohort study was conducted using the Medical Information Mart for Intensive Care-IV database, which includes records of patients admitted to the ICU at Beth Israel Deaconess Medical Center in Boston dating 2008 through 2019. Included patients were those aged 18 years or older and hospitalized in the ICU. Data were analyzed from March through May 2022.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Patients were divided into 2 groups according to dexmedetomidine exposure: those who received dexmedetomidine within 48 hours after ICU admission (dexmedetomidine group) and those who never received dexmedetomidine (no dexmedetomidine group).<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was the occurrence of NOAF within 7 days of ICU admission, as defined by the nurse-recorded rhythm status. Secondary outcomes were ICU length of stay, hospital length of stay, and in-hospital mortality.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n This study included 22\u202f237 patients before matching (mean [SD] age, 65.9 [16.7] years; 12\u202f350 male patients [55.5%]). After 1:3 propensity score matching, the cohort included 8015 patients (mean [SD] age, 61.0 [17.1] years; 5240 males [65.4%]), among whom 2106 and 5909 patients were in the dexmedetomidine and no dexmedetomidine groups, respectively. Use of dexmedetomidine was associated with a decreased risk of NOAF (371 patients [17.6%] vs 1323 patients [22.4%]; hazard ratio, 0.80; 95% CI, 0.71-0.90). Although patients in the dexmedetomidine group had longer median (IQR) length of stays in the ICU (4.0 [2.7-6.9] days vs 3.5 [2.5-5.9] days;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001) and hospital (10.0 [6.6-16.3] days vs 8.8 [5.9-14.0] days;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), dexmedetomidine was associated with decreased risk of in-hospital mortality (132 deaths [6.3%] vs 758 deaths [12.8%]; hazard ratio, 0.43; 95% CI, 0.36-0.52).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This study found that dexmedetomidine was associated with decreased risk of NOAF in patients with critical illness, suggesting that it may be necessary and warranted to evaluate this association in future clinical trials.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.9955","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T11:43:15Z","timestamp":1682422995000},"page":"e239955","source":"Crossref","is-referenced-by-count":18,"title":["Association of Dexmedetomidine With New-Onset Atrial Fibrillation in Patients With Critical Illness"],"prefix":"10.1001","volume":"6","author":[{"given":"Myung Jin","family":"Song","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonhoon","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Digital Healthcare, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Lee","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Heung","family":"Yoon","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Jung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Thoracic Surgery, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Young","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Digital Healthcare, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Yoon","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"issue":"7","key":"zoi230316r1","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/s001340051280","article-title":"Tachyarrhythmias in a surgical intensive care unit: a case-controlled epidemiologic study.","volume":"26","author":"Knotzer","year":"2000","journal-title":"Intensive Care Med"},{"issue":"1","key":"zoi230316r2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1164\/rccm.200701-031OC","article-title":"Incidence and prognosis of sustained arrhythmias in critically ill patients.","volume":"178","author":"Annane","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"zoi230316r3","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s00134-019-05633-x","article-title":"New-onset atrial fibrillation in adult critically ill patients: a scoping review.","volume":"45","author":"Wetterslev","year":"2019","journal-title":"Intensive Care Med"},{"issue":"1","key":"zoi230316r4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13054-020-2730-0","article-title":"New-onset atrial fibrillation and associated outcomes and resource use among critically ill adults\u2014a multicenter retrospective cohort study.","volume":"24","author":"Fernando","year":"2020","journal-title":"Crit Care"},{"issue":"6","key":"zoi230316r5","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.chest.2018.03.040","article-title":"Atrial fibrillation in the ICU.","volume":"154","author":"Bosch","year":"2018","journal-title":"Chest"},{"issue":"2","key":"zoi230316r6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4022\/jafib.v1i8.544","article-title":"The autonomic nervous system and atrial fibrillation: the roles of pulmonary vein isolation and ganglionated plexi ablation.","volume":"2","author":"Scherlag","year":"2009","journal-title":"J Atr Fibrillation"},{"issue":"2","key":"zoi230316r7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1164\/rccm.201603-0618OC","article-title":"Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis: a cohort study.","volume":"195","author":"Klein Klouwenberg","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"zoi230316r8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijcard.2018.03.051","article-title":"New-onset atrial fibrillation in critically ill patients and its association with mortality: a report from the FROG-ICU study.","volume":"266","author":"Arrigo","year":"2018","journal-title":"Int J Cardiol"},{"issue":"1","key":"zoi230316r9","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2019-001226","article-title":"Incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit.","volume":"7","author":"Jacobs","year":"2020","journal-title":"Open Heart"},{"key":"zoi230316r10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2022.100970","article-title":"Sex- and age specific association of new-onset atrial fibrillation with in-hospital mortality in hospitalised COVID-19 patients.","volume":"39","author":"Offerhaus","year":"2022","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"5","key":"zoi230316r11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1001\/jama.2009.56","article-title":"Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.","volume":"301","author":"Riker","year":"2009","journal-title":"JAMA"},{"issue":"2","key":"zoi230316r12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/00000542-200008000-00016","article-title":"The effects of increasing plasma concentrations of dexmedetomidine in humans.","volume":"93","author":"Ebert","year":"2000","journal-title":"Anesthesiology"},{"issue":"5","key":"zoi230316r13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/cc712","article-title":"Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care.","volume":"4","author":"Venn","year":"2000","journal-title":"Crit Care"},{"issue":"10","key":"zoi230316r14","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s40265-015-0419-5","article-title":"Dexmedetomidine: a review of its use for sedation in the intensive care setting.","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs"},{"issue":"2","key":"zoi230316r15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1213\/00000539-199902000-00042","article-title":"The effects of clonidine and dexmedetomidine on human neutrophil functions.","volume":"88","author":"Nishina","year":"1999","journal-title":"Anesth Analg"},{"issue":"12","key":"zoi230316r16","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1136\/heartjnl-2017-312150","article-title":"Epidemiology of new-onset atrial fibrillation following coronary artery bypass graft surgery.","volume":"104","author":"Filardo","year":"2018","journal-title":"Heart"},{"key":"zoi230316r17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2147\/DDDT","article-title":"Can dexmedetomidine reduce atrial fibrillation after cardiac surgery: a systematic review and meta-analysis.","volume":"12","author":"Zhu","year":"2018","journal-title":"Drug Des Dev Ther"},{"key":"zoi230316r18","doi-asserted-by":"publisher","first-page":"7507","DOI":"10.2147\/JIR.S346089","article-title":"Recent advances in the clinical value and potential of dexmedetomidine.","volume":"14","author":"Liu","year":"2021","journal-title":"J Inflamm Res"},{"issue":"10245","key":"zoi230316r19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0140-6736(20)30631-0","article-title":"Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial.","volume":"396","author":"Turan","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"zoi230316r21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ahj.2009.05.010","article-title":"Incidence of atrial fibrillation in Whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study.","volume":"158","author":"Alonso","year":"2009","journal-title":"Am Heart J"},{"issue":"9","key":"zoi230316r22","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.hrthm.2018.05.019","article-title":"Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: a systematic review.","volume":"15","author":"Ugowe","year":"2018","journal-title":"Heart Rhythm"},{"issue":"3","key":"zoi230316r23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","article-title":"Mice: multivariate imputation by chained equations in R.","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Softw"},{"issue":"10","key":"zoi230316r24","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1177\/0885066619866172","article-title":"Novel method of atrial fibrillation case identification and burden estimation using the MIMIC-III electronic health data set.","volume":"34","author":"Ding","year":"2019","journal-title":"J Intensive Care Med"},{"issue":"5","key":"zoi230316r25","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jtcvs.2007.07.021","article-title":"Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement.","volume":"134","author":"Austin","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"25","key":"zoi230316r26","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"8","key":"zoi230316r27","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/aje\/kwy049","article-title":"Relative performance of propensity score matching strategies for subgroup analyses.","volume":"187","author":"Wang","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"2","key":"zoi230316r28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/1536867X0900900206","article-title":"Further development of flexible parametric models for survival analysis.","volume":"9","author":"Lambert","year":"2009","journal-title":"Stata J"},{"issue":"3","key":"zoi230316r29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.annepidem.2006.10.009","article-title":"Test for additive interaction in proportional hazards models.","volume":"17","author":"Li","year":"2007","journal-title":"Ann Epidemiol"},{"issue":"6","key":"zoi230316r30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10654-011-9554-9","article-title":"Estimating measures of interaction on an additive scale for preventive exposures.","volume":"26","author":"Knol","year":"2011","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"zoi230316r31","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s13054-016-1480-5","article-title":"Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial.","volume":"20","author":"Liu","year":"2016","journal-title":"Crit Care"},{"issue":"2","key":"zoi230316r32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1536\/ihj.19-132","article-title":"Anxiety administrated by dexmedetomidine to prevent new-onset of postoperative atrial fibrillation in patients undergoing off-pump coronary artery bypass graft.","volume":"61","author":"Zi","year":"2020","journal-title":"Int Heart J"},{"issue":"8","key":"zoi230316r33","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jacc.2007.10.043","article-title":"Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery.","volume":"51","author":"Echahidi","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"zoi230316r34","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00134-022-06660-x","article-title":"Use of dexmedetomidine for sedation in mechanically ventilated adult ICU patients: a rapid practice guideline.","volume":"48","author":"M\u00f8ller","year":"2022","journal-title":"Intensive Care Med"},{"key":"zoi230316r35","doi-asserted-by":"publisher","DOI":"10.1177\/10600280221151170","article-title":"Niche roles for dexmedetomidine in the intensive care unit.","volume":"10600280221151170","author":"Wiegand","year":"2023","journal-title":"Ann Pharmacother"},{"issue":"1","key":"zoi230316r36","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13054-019-2446-1","article-title":"Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials.","volume":"23","author":"Santhakumaran","year":"2019","journal-title":"Crit Care"},{"issue":"4","key":"zoi230316r37","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00134-021-06356-8","article-title":"Early sedation with dexmedetomidine in ventilated critically ill patients and heterogeneity of treatment effect in the SPICE III randomised controlled trial.","volume":"47","author":"Shehabi","year":"2021","journal-title":"Intensive Care Med"},{"key":"zoi230316r20","unstructured":"Johnson? A, Bulgarelli? L, Pollard? T, Horng? S, Celi? LA, Mark? R. MIMIC-IV. PhysioNet. Accessed March 17, 2023. https:\/\/physionet.org\/content\/mimiciv\/1.0\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2804042\/song_2023_oi_230316_1681410455.66912.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T11:43:20Z","timestamp":1682423000000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2804042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.9955","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]}}}